Incyte Corp
corporate_fare Company Profile
Incyte Corp (NASDAQ:INCY) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 34 items for INCY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 18 rated 8 or above. Recent SEC coverage for INCY spans 10-Q, 8-K.
Recent high-impact activity:
- Povofortay Wins EU Approval as First Once-Daily Oral HS Treatment
- Incyte Posts $784.8M Q3 Loss on $1.23B Vega IPR&D Charge as Revenue Climbs 14%
- Incyte Swings to $3.60/Share Loss but Beats on Revenue, Tops Lowered Bar
- Incyte Lifts 2026 Sales Outlook as Q3 Revenue Climbs 14% to $1.56B
- Incyte Strikes CMS Deal for Jakafi Pricing, Secures Exemption from Future Mandates
Financial Snapshot
Short Interest & Short Volume
5.58 days to coverFINRA reported short interest of 10,649,327 shares in INCY as of the October 30, 2026 settlement, a 6.2% increase from the prior period — about 5.6 days to cover at its recent average daily volume. On November 20, 2026, 53.9% of INCY volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.